MedTrace Logo

Feasibility of the Vapor Nanobubble Technology for Malaria Diagnostics (MalariaSense)

NCT02672228 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2018-03-22

No results posted yet for this study

Summary

This is a proof of concept study that will evaluate the feasibility of a vapor nanobubble technology (MalariSense) for malaria diagnostics. The MalariSense technology will use a highly innovative approach based on the transdermal non-invasive detection of vapor nanobubbles produced by the excitation of malaria-specific hemozoin by safe, low-energy laser pulse. The objectives of this study will be to determine the sensitivity and specificity of MalariSense in diagnosing malaria in malaria suspected cases attending a health facility in The Gambia and to identify factors influencing the diagnostic accuracy of MalariSense

Conditions

Interventions

DEVICE

MalariaSense device

All participants enrolled in the study will be assessed for malaria using the intervention device called MalariaSense technology

Sponsors & Collaborators

  • Precision Acoustics ltd UK

    collaborator UNKNOWN

  • Standa, UAB Lithuania

    collaborator UNKNOWN

  • X Instruments LLC, CA, USA

    collaborator UNKNOWN

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Umberto D'alessandro, PhD, MD · Medical Research Council Unit, The Gambia

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • The Gambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02672228 on ClinicalTrials.gov